PEQKX
Price
$24.13
Change
-$0.05 (-0.21%)
Updated
Jun 5 closing price
Net Assets
848.36M
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
Interact to see
Advertisement

PEQKX vs RMEBX

Header iconPEQKX vs RMEBX Comparison
Open Charts PEQKX vs RMEBXBanner chart's image
Victory Pioneer Equity Income R6
Price$24.13
Change-$0.05 (-0.21%)
VolumeN/A
Net Assets848.36M
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
PEQKX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PEQKX vs. RMEBX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEQKX is a Hold and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. PEQKX (848M). PEQKX pays higher dividends than RMEBX: PEQKX (2.00) vs RMEBX (1.16). PEQKX was incepted earlier than RMEBX: PEQKX (12 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than PEQKX (0.68). PEQKX is a more actively managed with annual turnover of: 59.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than PEQKX: RMEBX (250) vs PEQKX (5000000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. PEQKX (-29.56). RMEBX return over 5 years is better than : 49.85 vs. PEQKX (-23.50).
PEQKXRMEBXPEQKX / RMEBX
Total Expense Ratio0.681.0764%
Annual Report Gross Expense Ratio0.681.0764%
Fund Existence12 years11 years-
Gain YTD-30.5575.349-571%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets848M105B1%
Annual Yield % from dividends2.001.16173%
Returns for 1 year-29.568.30-356%
Returns for 3 years-26.4617.96-147%
Returns for 5 years-23.5049.85-47%
Returns for 10 years-14.6268.21-21%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA